Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.73 |
| ▸ | LPAR1 | Q92633 | 9/20 | 0.70 |
| ▸ | LPAR3 | Q9UBY5 | 9/20 | 0.70 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.62 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.54 |
| ▸ | TLR2 | O60603 | 3/20 | 0.51 |
| ▸ | LPAR5 | Q9H1C0 | 6/20 | 0.49 |
| ▸ | LPAR6 | P43657 | 5/20 | 0.49 |
| ▸ | LPAR4 | Q99677 | 5/20 | 0.49 |
| ▸ | P2RY10 | O00398 | 2/20 | 0.48 |
| ▸ | AKT1 | P31749 | 2/20 | 0.46 |
| ▸ | PLCG2 | P16885 | 1/20 | 0.46 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.46 |
| ▸ | AKT2 | P31751 | 1/20 | 0.46 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.46 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.46 |
| ▸ | GAB1 | Q13480 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29133994 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL28622692 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL29206151 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL28622690 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL23300849 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL2702607 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL25394384 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL21568785 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL22092476 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D | |
| SCHEMBL29692534 | 1.00 | PLA2G2C (0.73) | PLA2G2CLPAR1LPAR3LPAR2PLA2G2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240293443-A1 | HEPARAN SULFATE MIMETICS TO IMPROVE GLUCOSE CLEARANCE | GORDTS PHILIP L S M (US) | 2024-09-05 | — | — | US | claimed |
| CN-112469826-B | Magnetic-based biopanning method by attachment of magnetic beads to cells | (株)爱恩德生物 | 2024-02-09 | — | — | CN | claimed |
| CN-117157104-A | Targeting multiple T cell types using spherical nucleic acid vaccine architecture | 西北大学 | 2023-12-01 | — | — | CN | claimed |
| CN-112469826-A | Magnetic based biopanning method by magnetic bead attachment to cells | (株)爱恩德生物 | 2021-03-09 | — | — | CN | claimed |
| US-9164108-B2 | Liposome-based microarray and methods of use thereof | SRI INTERNATIONAL (US) | 2015-10-20 | — | — | US | claimed |
| EP-2680004-A2 | Compositions and methods for detecting cancer | The Regents of the University of California (US) | 2014-01-01 | — | — | EP | claimed |
| US-20110177614-A1 | COMPOSITIONS AND METHODS FOR DETECTING CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2011-07-21 | — | — | US | claimed |
| EP-4694867-A2 | LIPID NANOPARTICLES FOR DELIVERY OF AGENTS | Massachusetts Institute of Technology (US) | 2026-02-18 | — | — | EP | disclosed |
| US-12508226-B2 | Lipid composition | FUJIFILM CORPORATION (JP) | 2025-12-30 | — | — | US | disclosed |
| US-20250320280-A1 | BROADLY NEUTRALIZING ANTIBODIES THAT TARGET HIV ENV V3 N-GLYCANS | UNIV ROCKEFELLER (US) | 2025-10-16 | — | — | US | disclosed |
| EP-4328309-B1 | LIPID COMPOSITION | FUJIFILM CORP (JP) | 2025-07-02 | — | — | EP | disclosed |
| US-12338277-B2 | Broadly neutralizing antibodies that target HIV ENV V3 N-glycans | THE ROCKEFELLER UNIVERSITY (US) | 2025-06-24 | — | — | US | disclosed |
| US-20250049713-A1 | LIPID NANOPARTICLES FOR DELIVERY OF AGENTS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2025-02-13 | — | — | US | disclosed |
| US-20120184461-A1 | PRINTING OF FSL CONSTRUCTS | BOVIN NICOLAI VLADIMIROVICH (RU) | 2012-07-19 | — | — | US | disclosed |
| EP-2449386-A1 | PRINTING OF FSL CONSTRUCTS | Bovin, Nikolai Vladimirovich (RU) | 2012-05-09 | — | — | EP | disclosed |
| US-20110177614-A1 | COMPOSITIONS AND METHODS FOR DETECTING CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2011-07-21 | — | — | US | disclosed |
| US-7906147-B2 | superparamagnetic nanoparticles of iron coated with bilayer of molecules:(a) layer of oleic acid in direct contact with the iron particles; (b) a layer of Tween\"; bilayer of surface binding molecules and amphiphatic molecules; self-assembles; solubilizing; reducing toxicity; gold in MRI and tomography | NANOPROBES, INC. (US) | 2011-03-15 | — | — | US | disclosed |
| WO-2011002310-A1 | PRINTING OF FSL CONSTRUCTS | BOVIN NICOLAI VLADIMIROVICH (RU) | 2011-01-06 | — | — | WO | disclosed |
| US-20080089836-A1 | superparamagnetic nanoparticles of iron coated with bilayer of molecules:(a) layer of oleic acid in direct contact with the iron particles; (b) a layer of Tween\"; bilayer of surface binding molecules and amphiphatic molecules; self-assembles; solubilizing; reducing toxicity; gold in MRI and tomography | NANOPROBES, INC. (US) | 2008-04-17 | — | — | US | disclosed |
| US-20040259142-A1 | Products and methods | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2004-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240293443-A1 | HEPARAN SULFATE MIMETICS TO IMPROVE GLUCOSE CLEARANCE | FABP4, APMAP, SLC2A4 | PLA2G2C 1147/4885LPAR1 2087/4885LPAR3 2020/4885 |
| US-20250049713-A1 | LIPID NANOPARTICLES FOR DELIVERY OF AGENTS | FABP3, LIPC, PHOSPHO1 | PLA2G2C 285/4885LPAR1 32/4885LPAR3 20/4885 |
| US-20080089836-A1 | superparamagnetic nanoparticles of iron coated with bilayer of molecules:(a) layer of oleic acid in direct contact with the iron particles; (b) a layer of Tween\"; bilayer of surface binding molecules and amphiphatic molecules; self-assembles; solubilizing; reducing toxicity; gold in MRI and tomography | TFRC, FABP1, SCARB1 | PLA2G2C 2431/4885LPAR1 232/4885LPAR3 322/4885 |
| US-12508226-B2 | Lipid composition | APOB, NAF1, SLC27A1 | PLA2G2C 559/4885LPAR1 7/4885LPAR3 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.